Disparities in uptake of new FDA-approved therapies for metastatic clear cell renal cell carcinoma.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Moffitt Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Flatiron Health
OpenAlex ID: W4391303244
